TFAM and metabolic dysfunction-associated steatotic liver disease: Through the investigation of the GSE33814 dataset, we discovered that CDKN1B and NDUFA4 expressions were reduced in NAFLD, whereas TFAM expression was elevated (Figures 7D–F).